The role of axillofemoral bypass in current vascular surgery practice

Nguyen, Khanh P.; Perrone, Kenneth H.; Rahman, Auddri; Azarbal, Amir F.; Liem, Timothy K.; Mitchell, Erica L.; Moneta, Gregory L.; Landry, Gregory J.

doi:10.1016/j.amjsurg.2016.02.003

Cited by 14 publications

(10 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…15 Patient survival rates were also low, although it has often been observed that this finding is probably related primarily to the population of patients in whom AxFB has generally been used (ie, poor candidates for open aortic surgery because of age, cardiopulmonary disease, renal insufficiency, infection, hostile aorta or abdomen, and other high-risk conditions). 3,11,14,16,17 In the 1990s, reports of better outcomes with AxFB began to appear. For example, in the study by Taylor et al 18 of 184 patients who underwent AxUFB or AxBFB using externally supported, 8-mm-diameter expanded polytetrafluoroethylene (ePTFE) grafts, the 5-year primary patency rate was 71%.…”

mentioning

confidence: 99%

Improved patency after axillofemoral bypass for aortoiliac occlusive disease

Samson

Showalter

Lepore

et al. 2018

Journal of Vascular Surgery

View full text Add to dashboard Cite

Our data indicate that AxBFB and AxUFB performed with the use of modern protocols and technology may render them an acceptable valid primary intervention in patients in whom endovascular treatment has failed or is unlikely to offer long-term success. The simplicity of performing these grafts and their low mortality and morbidity lend their application to surgeons with limited open aortic experience. Because AxUFB and AxBFB have similar patency rates, AxBFB should be reserved for bilateral indications.

show abstract

mentioning

confidence: 99%

Improved patency after axillofemoral bypass for aortoiliac occlusive disease

Samson

Showalter

Lepore

et al. 2018

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…Although the effectiveness of long-term anticoagulant and antiplatelet therapy is still controversial, those have been empirically used after arterial bypass surgeries. 10 Because the coagulation system shifts toward a hypercoagulable state during pregnancy, the patency of the bypass should be carefully monitored using color Doppler ultrasonography. However, it is not clear whether anticoagulation therapy is entirely essential.…”

Section: Discussionmentioning

confidence: 99%

Obstetrical management of patients with extra‐anatomic vascular bypass grafts due to Takayasu arteritis

Matsuda

Egawa

Isobe

et al. 2016

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Little is known about the obstetrical management of patients with Takayasu arteritis (TA) who have undergone extra-anatomic vascular bypass (EAVB). We describe two cases of EAVB. Case 1 underwent EAVB due to renovascular hypertension associated with stenosis of the abdominal aorta, and Case 2 due to amaurosis fugax episodes associated with stenosis of the brachiocephalic and left common carotid arteries. Pregnancy outcomes were favorable for both cases, though the original symptoms recurred during the third trimester in each case, possibly due to increased blood flow to the pregnant uterus. Neither bypass occlusion nor anastomotic aneurysm formation was observed. Pregnancy outcomes of patients with EAVB due to TA are favorable, although pregnancies of patients with TA who have cardiovascular complications are associated with an increased risk of maternal and fetal morbidity. The obstetrical management of these patients, however, should include monitoring for complications related to the EAVB.

show abstract

“…4) However, while AxFB has been applied for challenging cases with severe comorbidities, including for older patients than typically receive AoFB, the patients treated by AxFB have shown a lower overall survival rate (67.0% at 1 year) than those who undergo AoFB. 5) Therefore, it might be difficult for AxFB to be considered as a viable alternative treatment to AoFB.…”

Section: Introductionmentioning

confidence: 99%

The Comparison of Long-Term Results between Aortofemoral and Axillofemoral Bypass for Patients with Aortoiliac Occlusive Disease

Igari

Kudo

Katsui

et al. 2020

ATCS

View full text Add to dashboard Cite

Purpose: We evaluated the clinical outcomes of aortofemoral bypass (AoFB) and axillofemoral bypass (AxFB) surgeries for complex aortoiliac occlusive disease (AIOD) and compared them from the perspectives of safety and efficacy. Methods: We retrospectively reviewed 21 patients with AoFB grafting and 9 patients with AxFB grafting. The demographic information of the patients was examined, and the intra-, peri-, and postoperative results as well as long-term outcomes were evaluated. Results: In the AoFB, 2 of 21 (9.5%) cases had intra-and perioperative complications, and 4 of 21 (19.0%) cases had postoperative complications; however, there were no postoperative mortalities. In the AxFB, two of nine (22.2%) cases had postoperative graft thrombosis; however, again there were no postoperative mortalities. According to Kaplan-Meier analysis, the primary patency rates in the AoFB and AxFB groups at 5 years were 94.8% and 53.6%, respectively (P = 0.001), while the limb salvage rates at 5 years were 96.4% and 92.9%, respectively (P = 0.320). Conclusions: Even though the patency rates with AxFB grafting were inferior to those with AoFB grafting, AxFB was able to achieve equivalent limb salvage rates and should thus be considered as an alternative treatment method, especially when limb salvage is a goal.

show abstract

The role of axillofemoral bypass in current vascular surgery practice

Cited by 14 publications

References 13 publications

Improved patency after axillofemoral bypass for aortoiliac occlusive disease

Improved patency after axillofemoral bypass for aortoiliac occlusive disease

Obstetrical management of patients with extra‐anatomic vascular bypass grafts due to Takayasu arteritis

The Comparison of Long-Term Results between Aortofemoral and Axillofemoral Bypass for Patients with Aortoiliac Occlusive Disease

Contact Info

Product

Resources

About